When treatment does not work: failure to understand failure

Except for specific content provided by a third party, Copyright © 2018 Elsevier Limited. Lancet is a trademark of Elsevier Limited. The Lancet.com website is powered by Elsevier Inc. The contents of this website are intended for medical professionals. Cookies are set up on this website. To see refusal or details, please see the cookie page. Lancet shows accessibility efforts by providing access and optimization for people with disabilities and people with disabilities.

Claims for occupational responsibility related to periodontal disease are increasing. These claims usually refer to diagnostic failures, not notified, not mentioned or failed treatment. Adverse events and surgical failure or nonsurgical treatment during treatment rarely produced an assertion. Most allegations of periodontal disease are suspected to be directed to general dentists. Claims based on periodontal disease often have common features. Firstly, the claimant quit the clinic or was seen by a subsequent treatment dentist. Normally, the diagnosis of periodontal disease by a new dentist will cause the patient to conclude that the diagnosis should also be made by the previous dentist. Second, recently there is no so-called behavior or dropout. Most perio claims include alleged delays in diagnosis or treatment, resulting in injury claims

It is necessary to distinguish between failure to eradicate malarial parasitemia or dealing with clinical disease and true antimalarial drug resistance after treatment with antimalarial drugs. Drug resistance can lead to treatment failure, but not all treatment failures are due to drug resistance. Many factors, including the level of inhibition required to inhibit heme polymerization, can lead to treatment failure (52). This chloroquine outflow occurs 40 to 50 times faster than the susceptibility locus of the resistance locus (53). Further evidence supporting this mechanism is that chloroquine resistance can be reversed by drugs that interfere with this elimination system (54). Whether or not the resistance of parasites to other quinoline antimalarials (amodikin, mefloquine, halogenated quinones and quinine) occurs by a similar mechanism is unknown (52).

¿ Although 1/2 recurrence is an essential part of substance abuse, failure of treatment is not necessarily due to disease. Conversely, treatment planning is not suitable for individual drug abusers, so some therapies fail. Therefore, experts need to talk with parents about possible causes when treatment efforts fail. ¿ Experts also need to understand the extent and type of treatment service available in each community. Unfortunately, depending on the community, drug abuse treatment services are limited and may not be able to meet the needs of many customers. In this case, experts can become supporters and inform the community that new services and extended services are needed.